bioRxivCancer Biology
Quantifying the patterns of metabolic plasticity and heterogeneity along the epithelial-hybrid-mesenchymal spectrum in cancer
S. Muralidharan, S. Sahoo, A. Saha, S. Chandran, S. S. Majumdar, H. Levine, M. K. Jolly
Abstract
Cancer metastasis is the leading cause of cancer-related mortality and the process of Epithelial to Mesenchymal Transition (EMT) is crucial for cancer metastasis. Either a partial or complete EMT have been reported to influence the metabolic plasticity of cancer cells in terms of switching among oxidative phosphorylation, fatty acid oxidation and glycolysis pathways. However, a comprehensive analysis of these major metabolic pathways their associations with EMT across different cancers is lacking. Here, we analyse more than 180 cancer cell datasets and show diverse associations of these metabolic pathways with the EMT status of cancer cells. Our bulk data analysis shows that EMT generally positively correlates with glycolysis but negatively with oxidative phosphorylation and fatty acid metabolism. These correlations are also consistent at the level of their molecular master regulators, namely AMPK and HIF1. Yet, these associations are shown to not be universal. Analysis of singlecell data of EMT induction shows dynamic changes along the different axes of metabolic pathways, consistent with general trends seen in bulk samples. Together, our results reveal underlying patterns of metabolic plasticity and heterogeneity as cancer cells traverse through the epithelial-hybrid-mesenchymal spectrum of states.
- organism: human
- assay: bulk RNA-seq
- research focus: metabolism & bioenergetics
- research focus: cell type annotation
- research focus: clustering
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer
M. L. Galbraith, H. L. Levine, … D. Jia·bioRxiv·Aug 2, 2022
- Epithelial-mesenchymal transition is the main driver of intrinsic metabolism in cancer cell lines
Sarah Cherkaoui, Stephan Durot, … Nicola Zamboni·Molecular Systems BiologyPeer-reviewed·Nov 1, 2022
- Towards Decoding the Metabolic Plasticity in Cancer: Coupling of Gene Regulation and Metabolic Pathways
Dongya Jia, Mingyang Lu, … Herbert Levine·bioRxiv·Sep 27, 2018
- PD-L1 activity is associated with partial EMT and metabolic reprogramming in carcinomas
S. Muralidharan, M. Sehgal, … M. K. Jolly·bioRxiv·Oct 5, 2022
- Constraint-based modeling identifies metabolic vulnerabilities during the epithelial to mesenchymal transition
S. E. Campit, V. G. Keshamouni, S. Chandrasekaran·bioRxiv·Jan 31, 2022
- Multiple distinct metastatic cell states are induced by epithelial-mesenchymal plasticity
Fahda Alsharief, Robert K. Suter, … Gray W. Pearson·bioRxiv·Aug 15, 2025